Brief: Verrica Pharmaceuticals Says As Result Of Craig Ballaron's Resignation, Co Temporarily Not In Compliance With Nasdaq Listing Requirements
08/10/2024 21:41
Oct 8 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O :
* VERRICA PHARMACEUTICALS INC: AS A RESULT OF CRAIG
BALLARON'S
RESIGNATION, CO TEMPORARILY NOT IN COMPLIANCE WITH NASDAQ
LISTING REQUIREMENTS
Source text for Eikon: ID:n0001193125-24-234391
Further company coverage: VRCA.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data